scholarly journals Establishment of a fluorescentin situhybridization assay for imaging hepatitis B virus nucleic acids in cell culture models

2017 ◽  
Vol 6 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Xiaonan Zhang ◽  
Lei Yue ◽  
Zhanqing Zhang ◽  
Zhenghong Yuan
2018 ◽  
Vol 92 (23) ◽  
Author(s):  
Luhua Qiao ◽  
Jianhua Sui ◽  
Guangxiang Luo

ABSTRACTHepatitis B virus (HBV) is a major cause of chronic liver diseases, including hepatitis, cirrhosis, and hepatocellular carcinoma. HBV research has been hampered by the lack of robust cell culture and small animal models of HBV infection. The discovery of sodium taurocholate cotransporting polypeptide (NTCP) as an HBV receptor has been a landmark advance in HBV research in recent years. Ectopic expression of NTCP in nonpermissive HepG2, Huh7, and AML12 cell lines confers HBV susceptibility. However, HBV replication in these human and murine hepatocyte cell lines appeared suboptimal. In the present study, we constructed stable NTCP-expressing HepG2 and AML12 cell lines and found that HBV permissiveness is correlated with NTCP expression. More significantly, we developed robust HBV cell culture models by treating the HBV-infected cells with dimethyl sulfoxide (DMSO) and hydrocortisone, which significantly promoted HBV replication and production. Mechanistic studies suggested that hydrocortisone significantly enhanced the transcription and expression of PGC1α and HNF4α, which are known to promote HBV transcription and replication. These new human and murine hepatocyte culture systems of HBV infection and replication will accelerate the determination of molecular aspects underlying HBV infection, replication, and morphogenesis in human and murine hepatocytes. We anticipate that our HBV cell culture models will also facilitate the discovery and development of antiviral drugs towards the ultimate eradication of chronic hepatitis B virus infection.IMPORTANCEHBV research has been greatly hampered by the lack of robust cell culture and small animal models of HBV infection and propagation. The discovery of NTCP as an HBV receptor has greatly impacted the field of HBV research. Although HBV infection of NTCP-expressing human and murine hepatocyte cell lines has been demonstrated, its replication in cell culture appeared inefficient. To further improve cell culture systems of HBV infection and replication, we constructed NTCP-expressing HepG2 and AML12 cell lines that are highly permissive to HBV infection. More significantly, we found that DMSO and hydrocortisone markedly enhanced HBV transcription and replication in human and murine hepatocytes when added to the cell culture medium. These new cell culture models of HBV infection and replication will facilitate HBV research and antiviral drug discovery towards the ultimate elimination of chronic hepatitis B virus infection.


2003 ◽  
Vol 71 (1) ◽  
pp. 24-30 ◽  
Author(s):  
Wei Zhang ◽  
Hans Jörg Hacker ◽  
Mehmet Tokus ◽  
Thomas Bock ◽  
Claus H. Schröder

2019 ◽  
Vol 27 (3) ◽  
pp. 389-400 ◽  
Author(s):  
Mohammad K. Parvez ◽  
Md. Tabish Rehman ◽  
Perwez Alam ◽  
Mohammed S. Al-Dosari ◽  
Saleh I. Alqasoumi ◽  
...  

2010 ◽  
Vol 48 (12) ◽  
pp. 4487-4494 ◽  
Author(s):  
Shuhei Hige ◽  
Yoichi Yamamoto ◽  
Shigeru Yoshida ◽  
Tomoe Kobayashi ◽  
Hiromasa Horimoto ◽  
...  

2010 ◽  
Vol 84 (18) ◽  
pp. 9326-9331 ◽  
Author(s):  
Zhensheng Zhang ◽  
Eun Sun ◽  
Jing-hsiung James Ou ◽  
T. Jake Liang

ABSTRACT The X protein (HBX) of the hepatitis B virus (HBV) is essential for HBV productive infection in vivo. Our previous study (Z. Hu, Z. Zhang, E. Doo, O. Coux, A. L. Goldberg, and T. J. Liang, J. Virol. 73:7231-7240, 1999) shows that interaction of HBX with the proteasome complex may underlie the pleiotropic functions of HBX. Previously, we demonstrated that HBX affects hepadnaviral replication through a proteasome-dependent pathway in cell culture models. In the present study, we studied the effect of the proteasome inhibitor MLN-273 in two HBV mouse models. We demonstrated that administration of MLN-273 to transgenic mice containing the replication-competent HBV genome with the defective HBX gene substantially enhanced HBV replication, while the compound had a minor effect on wild-type HBV transgenic mice. Similar results were obtained by using C57BL/6 mice infected with recombinant adenoviruses expressing the replicating HBV genome. Our data suggest that HBV replication is subjected to regulation by cellular proteasome and HBX functions through the inhibition of proteasome activities to enhance HBV replication in vivo.


Sign in / Sign up

Export Citation Format

Share Document